Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...

From the moment we could look up to the skies, humanity has dreamt of what’s up there. And once we got there, how could we master it? And now that we’re there all the time, how can we use it? In 2025, ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

For years, pharmaceutical scientists have sought to enhance bioavailability by transforming drugs from their crystalline state into more soluble, amorphous forms. Traditional methods like spray drying ...

This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...

President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production sites ...

This spring, the Trump administration renewed calls to bring drug manufacturing and production back to American shores, reigniting debate about what it will take to move onshoring from a lofty dream ...

When Adam Kovalčík flew to Ohio for an international science competition, he did not expect to come home with $100,000. The 19-year-old from Dulovce, Slovakia won that sum on Friday, though, because ...